Medical Supplies & Devices Equity Analyst Marcus discusses 4Q earnings with Investor Relations Kyle Rose on a conference call to be held on February 27 at 12 pm hosted by JPMorgan.Webcast Link
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ENOV:
- Enovis reports Q4 adjusted EPS 95c, consensus 84c
- Enovis sees FY26 adjusted EPS $3.52-$3.73, consensus $3.42
- ENOV Earnings Report this Week: Is It a Buy, Ahead of Earnings?
- Enovis: Discounted Valuation and Improving Profitability Support Buy Rating Despite Near-Term Growth Headwinds
- Enovis sees FY25 sales $2.24B-$2.25B, consensus $2.26B